Please login to the form below
9
Revenue 2017Gilead Sciences
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Gilead Sciences' 2013 sales performance.
Daily brief: Novartis spends big on ezcema,
Kite invests in Gadeta’s gamma delta T cell receptors. Gilead acquired Kite last year for its leadership in cutting edge CAR-T drugs – and the now approved Yescarta – and now ... Alessandro Riva, MD, Gilead's executive vice president, Oncology
MaxCyte gets green light for solid tumour cell therapy
The current generation of CAR-T therapies – namely Novartis’Kymriah (tisagenlecleucel) and Gilead/Kite’s Yescarta (axicabtagene ciloleucel) – use engineered T cells harvested from blood, which have to be expanded in
Gilead’s Biktarvy gets European approval, setting up battle with GSK
The drug could offset Gilead's disappointing hep C franchise. Gilead has gained European approval for its new HIV combination therapy Biktarvy, hot on the heels of GSK's rival Juluca. ... The single tablet regimen (STR) is a combination of integrase
Trial data suggest Abivax’ drug may clear latent HIV
Other companies are also pursuing eradication strategies for HIV, including Gilead Sciences which reported encouraging data from an animal study earlier this year indicating that a two-drug regimen was able
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Business Unit Head, Medical Communications, London
-
Excellent package
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
-
Senior Account Manager
-
Competitive salary commensurate with experience
Subscribe to our email news alerts
- Moving annual total (MAT)
- Brexit rebels win vote on European Medicines Agency alignment
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- MaxCyte gets green light for solid tumour cell therapy
- NHS England to Vertex: come clean on Orkambi offer
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Random42 win Creativity International Award for Scientific Animation
- Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
- Aurora partners with PIPHealth and taps into patient panels
- FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
- Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
- OUTiCO growth in multi-channel creates more job openings
PMHub
Quintiles
With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
